COSMO PHARMACEUTICALS

Cosmo Pharmaceuticals Completes Phase II Enrollment for Distal Ulcerative Colitis Treatment Program

geneonline.com · 18 days ago

Number of shareholders of Cosmo Pharmaceuticals NV – FWB:C43

TradingView · about 1 month ago

Cosmo Pharmaceuticals (SWX:COPN) Valuation Reassessed After Strong Phase III Alopecia Results And Regulatory Plans

simplywall.st · about 1 month ago

Cosmo Pharmaceuticals Reports Positive 12-Month Safety Data for Clascoterone 5% in Male AGA

Dermatology Times · about 2 months ago

Does Cosmo Pharmaceuticals' (SWX:COPN) New €2.10 Dividend Clarify Its Capital Allocation Priorities?

simplywall.st · about 2 months ago

Cosmo Pharmaceuticals (CMOPF) Stock Price, News & Analysis

MarketBeat · 3 months ago

Is It Time To Reassess Cosmo Pharmaceuticals (SWX:COPN) After The Recent Share Price Pullback

simplywall.st · 3 months ago

Is It Too Late To Consider Cosmo Pharmaceuticals (SWX:COPN) After A 75% One Year Surge?

Yahoo Finance · 3 months ago

Cosmo Pharmaceuticals N.V. 2025 Q4 - Results - Earnings Call Presentation (OTCMKTS:CMOPF) 2026-03-10

Seeking Alpha · 3 months ago

Cosmo Pharmaceuticals (SWX:COPN) Swings To Loss And Tests Bullish Profitability Narratives

simplywall.st · 3 months ago

Cosmo Pharmaceuticals' 2025 recurring revenue rises, proposes dividend

TradingView · 3 months ago

Cosmo Pharmaceuticals Achieves 104.2M Revenue and 9.5M EBITDA in 2025; Proposes 2.10 Dividend; Establishes 2026 Growth Framework

TMX Newsfile · 3 months ago

Cosmo Pharmaceuticals Achieves 104.2M Revenue and 9.5M EBITDA in 2025; Proposes 2.10 Dividend; Establishes 2026 Growth Framework

TradingView · 3 months ago

Assessing Cosmo Pharmaceuticals (SWX:COPN) Valuation After Strong Multi Year Returns And Recent Share Price Pullback

Yahoo Finance · 3 months ago

Cosmo Pharmaceuticals execs head to London, Miami, Paris for investor talks

Stock Titan · 4 months ago

Cosmo Pharmaceuticals Announces Private Placement of Treasury Shares

TMX Newsfile · 4 months ago

Are Robust Financials Driving The Recent Rally In Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Stock?

Yahoo Finance · 5 months ago

Cosmo Pharmaceuticals Shares Surge After Male Hair Loss Treatment Delivers Breakthrough Phase III Results

Global Cosmetics News · 6 months ago

Cosmo Pharmaceuticals (SWX:COPN) Is Up 46.9% After Expanding Its Clascoterone Dermatology Franchise

Yahoo Finance · 6 months ago

Cosmo Pharmaceuticals N.V.'s (VTX:COPN) biggest owners are private companies who got richer after stock soared 5.6% last week

Yahoo Finance · 8 months ago